Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

about

Interaction of human enterochromaffin cells with human enteric adenovirus 41 leads to serotonin release and subsequent activation of enteric glia cells.

P2860

Q47549177-34115F2F-0781-45BD-820D-7C063FD921B1

P2860

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

Item

http://www.wikidata.org/entity/Q47166341

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@en

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@nl

type

Item

label

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@en

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@nl

prefLabel

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@en

Ondansetron treatment reduces ...... nded placebo-controlled trial.

@nl

P1476

Ondansetron treatment reduces ...... inded placebo-controlled trial

@en

P2093

Johan Nordgren

http://www.w3.org/2001/XMLSchema#string

Magnus Lindh

http://www.w3.org/2001/XMLSchema#string

Malin Ekström

http://www.w3.org/2001/XMLSchema#string

Maria Andersson

http://www.w3.org/2001/XMLSchema#string

Marie Hagbom

http://www.w3.org/2001/XMLSchema#string

Younis Khalid

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of intestinal and systemic rotavirus infection

Rotaviruses: from pathogenesis to vaccination

Global burden of childhood pneumonia and diarrhoea

Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients.

Oral ondansetron versus domperidone for symptomatic treatment of vomiting during acute gastroenteritis in children: multicentre randomized controlled trial.

Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.

Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin.

Pathogenesis of rotavirus diarrhea.

Oral ondansetron for gastroenteritis in a pediatric emergency department.

P304

e0186824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186824

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D P Novak

Lennart Svensson

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29077725

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5659648

http://www.w3.org/2001/XMLSchema#string

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

about

P2860

P2860

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932